Cargando…

Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up

BACKGROUND: The aim of this study was to investigate the prognostic value of the PAM50 intrinsic subtypes and risk of recurrence (ROR) score in patients with early breast cancer and long-term follow-up. A special focus was placed on hormone receptor-positive/human epidermal growth factor receptor 2-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohnstad, Hege O., Borgen, Elin, Falk, Ragnhild S., Lien, Tonje G., Aaserud, Marit, Sveli, My Anh T., Kyte, Jon A., Kristensen, Vessela N., Geitvik, Gry A., Schlichting, Ellen, Wist, Erik A., Sørlie, Therese, Russnes, Hege G., Naume, Bjørn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686844/ https://www.ncbi.nlm.nih.gov/pubmed/29137653 http://dx.doi.org/10.1186/s13058-017-0911-9

Ejemplares similares

Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
por: Lien, Tonje G., et al.
Publicado: (2021)

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
por: Tekpli, Xavier, et al.
Publicado: (2019)

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
por: Molloy, Timothy J, et al.
Publicado: (2011)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
por: Zhao, Xi, et al.
Publicado: (2014)

Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform
por: Dorraji, Esmaeil, et al.
Publicado: (2022)

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
por: Sas‐Chen, Aldema, et al.
Publicado: (2016)

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
por: Engebraaten, Olav, et al.
Publicado: (2012)

DNA methylation at enhancers identifies distinct breast cancer lineages
por: Fleischer, Thomas, et al.
Publicado: (2017)

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
por: Ohnstad, Hege O, et al.
Publicado: (2011)

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
por: Borgen, Elin, et al.
Publicado: (2018)

Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors
por: Bergholtz, Helga, et al.
Publicado: (2022)

eEF2K—a new target in breast cancers with combined inactivation of p53 and PTEN
por: Russnes, Hege G, et al.
Publicado: (2014)

Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
por: Synnestvedt, Marit, et al.
Publicado: (2012)

Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
por: Røssevold, Andreas Hagen, et al.
Publicado: (2022)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
por: Staaf, Johan, et al.
Publicado: (2022)

ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
por: Kyte, J. A., et al.
Publicado: (2020)

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
por: Höglander, Elen Kristine, et al.
Publicado: (2018)

Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
por: Bergholtz, Helga, et al.
Publicado: (2020)

Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
por: Gilje, Bjørnar, et al.
Publicado: (2014)

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2011)

Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2013)

DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic Hybridisation
por: Kresse, Stine H., et al.
Publicado: (2010)

Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome
por: Naume, B, et al.
Publicado: (2005)

Quantitative Multigene FISH on Breast Carcinomas Identifies der(1;16)(q10;p10) as an Early Event in Luminal A Tumors
por: Rye, Inga H, et al.
Publicado: (2015)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017)

Breast cancer quantitative proteome and proteogenomic landscape
por: Johansson, Henrik J., et al.
Publicado: (2019)

Allele-specific disparity in breast cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2011)

NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
por: Fu, Yi-Ping, et al.
Publicado: (2010)

Single-track sequencing for genotyping of multiple SNPs in the N-acetyltransferase 1 (NAT1) gene
por: Soucek, Pavel, et al.
Publicado: (2004)

ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
por: Kyte, J. A., et al.
Publicado: (2020)

Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression
por: Xu, Haifeng, et al.
Publicado: (2021)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

The multitude of molecular analyses in cancer: the opening of Pandora’s box
por: Russnes, Hege G, et al.
Publicado: (2014)

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
por: Kresse, Stine H, et al.
Publicado: (2008)

GoIFISH: a system for the quantification of single cell heterogeneity from IFISH images
por: Trinh, Anne, et al.
Publicado: (2014)

The LEPSIS Pam-File
por: DELPHI Collaboration
Publicado: (1982)

Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
por: Tinholt, Mari, et al.
Publicado: (2020)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmqf6tca6to5r6rip1f80i1k77